Cargando…

Economic Outcomes of Isavuconazole to Prevent Invasive Fungal Infection in Immunocompromised Adults: Initial Experience at an Academic Medical Center

BACKGROUND: Isavuconazole (ISA) is a once-daily, extended-spectrum triazole approved for treatment of invasive aspergillosis and mucormycosis. The pharmacokinetic profile, daily dosing, lack of therapeutic drug monitoring (TDM) and reduced cost make ISA a promising option for use as prophylaxis for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalewska, Christina A, Tallman, Gregory B, Pham, Aaron N, Lewis, James S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630875/ http://dx.doi.org/10.1093/ofid/ofx163.1264

Ejemplares similares

Isavuconazole for invasive fungal infections
Publicado: (2020)

2106. Evaluation of Isavuconazole for the Prophylaxis and Treatment of Invasive Fungal Infections at a Large Academic Medical Center
por: Vu, Christine, et al.
Publicado: (2019)

Role of isavuconazole in the treatment of invasive fungal infections
por: Wilson, Dustin T, et al.
Publicado: (2016)

Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
por: Zimmermann, Philippe, et al.
Publicado: (2022)

1726. Patterns of Isavuconazole Use for Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2022)

Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
por: Zhang, Tingting, et al.
Publicado: (2022)

819. Experience with Isavuconazole Use for Treatment of Invasive Fungal Infections
por: Gow-Lee, Vanessa, et al.
Publicado: (2023)

Real-World Use – Isavuconazole at a Large Academic Medical Center
por: Hassouna, HabiBA, et al.
Publicado: (2017)

Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
por: Falci, Diego R, et al.
Publicado: (2013)

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
por: Zurl, Christoph, et al.
Publicado: (2020)

Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience
por: Salas, Maria Queralt, et al.
Publicado: (2022)

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system
por: Schwartz, Stefan, et al.
Publicado: (2020)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients
por: Bellanger, Anne-Pauline, et al.
Publicado: (2019)

Acute invasive fungal sinusitis in immunocompromised children
por: Kebudi, Rejin
Publicado: (2022)

Real-World, Multicenter Case Series of Patients Treated with Isavuconazole for Invasive Fungal Disease in China
por: Wu, Lisha, et al.
Publicado: (2023)

Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole
por: Soysal, Ahmet
Publicado: (2015)

Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities: A Multi-Center Retrospective Study
por: Batista, Marjorie Vieira, et al.
Publicado: (2023)

Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK
por: Bagshaw, Emma, et al.
Publicado: (2018)

Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts
por: Antinori, Spinello, et al.
Publicado: (2018)

Radionuclide Imaging of Invasive Fungal Disease in Immunocompromised Hosts
por: Lawal, Ismaheel O., et al.
Publicado: (2021)

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
por: Kinch, Amelie, et al.
Publicado: (2022)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)

Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016)

Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease
por: Nwankwo, Lisa, et al.
Publicado: (2022)

360. Breakthrough Invasive Pulmonary Aspergillosis During Isavuconazole Prophylaxis in Patients with Hematologic Malignancies: A Single-Center Experience
por: Fontana, Lauren, et al.
Publicado: (2018)

Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations
por: Li, Julius, et al.
Publicado: (2015)

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
por: Perfect, John R., et al.
Publicado: (2018)

Isavuconazole: A Promising Salvage Therapy for Invasive Mucormycosis
por: Shafiq, Muhammad, et al.
Publicado: (2018)

Isavuconazole for COVID-19-Associated Invasive Mold Infections
por: Ullah, Nadir, et al.
Publicado: (2022)

2110. Treatment of Coccidioidomycosis with Isavuconazole
por: Jamros, Christina, et al.
Publicado: (2019)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Editorial: Invasive fungal disease in the immunocompromised host/Research Topic proceedings of the mycology 2021 meeting
por: Agrawal, Samir, et al.
Publicado: (2022)

Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)
por: Kovanda, Laura L., et al.
Publicado: (2016)

Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies
por: Hamed, Kamal, et al.
Publicado: (2023)

Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients
por: Silveira, Mariana L. C., et al.
Publicado: (2019)

Gastric Mucormycosis: An Infection of Fungal Invasion into the Gastric Mucosa in Immunocompromised Patients
por: Naqvi, Haider A., et al.
Publicado: (2020)

Chronic Invasive Fungal Rhinosinusitis with Atypical Clinical Presentation in an Immunocompromised Patient
por: Kawaji-Kanayama, Yuka, et al.
Publicado: (2020)

A 5-Year Review of Invasive Fungal Infection at an Academic Medical Center
por: Li, Yaling, et al.
Publicado: (2020)

Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c9ueach50s1ojnil5idd8r5nd2